Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now displayed and the prior government funding status notice has been removed. The page’s primary study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice added about government funding status and NIH Clinical Center operations (with guidance to opm.gov); page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary visibility was added and UI labels were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The page revision was bumped to v3.4.0, replacing the previous wording for these items. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3; this is a minor UI/metadata update with no impact on study content — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized to consolidate Florida, Indiana, and Ohio under a single 'Locations' heading, replacing separate 'Florida Locations', 'Indiana Locations', and 'Ohio Locations' entries. The page revision updated to v3.3.3.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the revision to v3.3.2. Removed the earlier PubMed publications note referencing revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.